SE502285C2 - Brusande farmaceutisk komposition innehållande ranitidin, samt förfarande för dess framställning - Google Patents

Brusande farmaceutisk komposition innehållande ranitidin, samt förfarande för dess framställning

Info

Publication number
SE502285C2
SE502285C2 SE8902288A SE8902288A SE502285C2 SE 502285 C2 SE502285 C2 SE 502285C2 SE 8902288 A SE8902288 A SE 8902288A SE 8902288 A SE8902288 A SE 8902288A SE 502285 C2 SE502285 C2 SE 502285C2
Authority
SE
Sweden
Prior art keywords
pharmaceutical composition
weight
composition according
ranitidine
citrate
Prior art date
Application number
SE8902288A
Other languages
English (en)
Swedish (sv)
Other versions
SE8902288L (sv
SE8902288D0 (sv
Inventor
Alain E E Schaeffer
Original Assignee
Glaxo Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Sa filed Critical Glaxo Lab Sa
Publication of SE8902288D0 publication Critical patent/SE8902288D0/xx
Publication of SE8902288L publication Critical patent/SE8902288L/
Publication of SE502285C2 publication Critical patent/SE502285C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8902288A 1988-06-24 1989-06-22 Brusande farmaceutisk komposition innehållande ranitidin, samt förfarande för dess framställning SE502285C2 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8808497A FR2633181B1 (fr) 1988-06-24 1988-06-24 Composition pharmaceutique a base de ranitidine et son procede de preparation

Publications (3)

Publication Number Publication Date
SE8902288D0 SE8902288D0 (sv) 1989-06-22
SE8902288L SE8902288L (sv) 1989-12-25
SE502285C2 true SE502285C2 (sv) 1995-09-25

Family

ID=9367671

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8902288A SE502285C2 (sv) 1988-06-24 1989-06-22 Brusande farmaceutisk komposition innehållande ranitidin, samt förfarande för dess framställning

Country Status (32)

Country Link
US (1) US5102665A (it)
JP (1) JPH0786086B2 (it)
KR (1) KR940002662B1 (it)
AT (1) AT396426B (it)
AU (1) AU627194B2 (it)
BE (1) BE1005691A4 (it)
CA (1) CA1329130C (it)
CH (1) CH679276A5 (it)
CY (1) CY1637A (it)
CZ (1) CZ280886B6 (it)
DE (1) DE3920626C2 (it)
DK (1) DK170223B1 (it)
ES (1) ES2015717A6 (it)
FR (1) FR2633181B1 (it)
GB (1) GB2219940B (it)
HK (1) HK33192A (it)
HU (1) HU210067A9 (it)
IE (1) IE60725B1 (it)
IL (1) IL90731A (it)
IT (1) IT1232149B (it)
LU (1) LU87541A1 (it)
MY (1) MY106412A (it)
NL (1) NL8901596A (it)
NZ (1) NZ229698A (it)
PH (1) PH26018A (it)
PT (1) PT90962B (it)
SA (1) SA90100095B1 (it)
SE (1) SE502285C2 (it)
SG (1) SG21892G (it)
SK (1) SK403891A3 (it)
ZA (1) ZA894787B (it)
ZW (1) ZW7889A1 (it)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU627775B2 (en) * 1988-09-20 1992-09-03 Glaxo Group Limited Pharmaceutical compositions
DE4027927A1 (de) * 1990-09-04 1992-03-05 Bayer Ag Brausekomponente und verfahren zu ihrer herstellung
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions
CA2055661A1 (en) * 1990-12-21 1992-06-22 Manley A. Paulos Treatment of upset stomach associated with heartburn, sour stomach or acid indigestion with an effervescent h2 blocker formulation
US5629013A (en) * 1991-04-04 1997-05-13 The Procter & Gamble Company Chewable calcium carbonate antacid tablet compositions
FR2700669B1 (fr) * 1993-01-22 1995-04-14 Tassoni Jean Pierre Composition effervescente pour la préparation de boissons gazeuses.
US5503846A (en) * 1993-03-17 1996-04-02 Cima Labs, Inc. Base coated acid particles and effervescent formulation incorporating same
US5407687A (en) * 1994-02-22 1995-04-18 Glaxo Inc. Ranitidine solid dosage form
IL112779A (en) * 1994-03-01 1999-11-30 Gergely Gerhard Granular product or tablet containing an efferescent system and an active pharmaceutical substance and its preparation
US5538737A (en) * 1994-11-30 1996-07-23 Applied Analytical Industries, Inc. Oral compositions of H2 -antagonists
SE512835C2 (sv) * 1996-01-08 2000-05-22 Astrazeneca Ab Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare
AU712710B2 (en) * 1996-05-17 1999-11-11 Merck Sharp & Dohme Corp. Effervescent bisphosphonate formulation
US5728401A (en) * 1997-04-16 1998-03-17 Ranbaxy Laboratories, Ltd. Effervescent ranitidine formulations
HUP9701293A3 (en) * 1997-07-25 1999-08-30 Chinoin Gyogyszer Es Vegyeszet New salts without unsavoury taste and pharmaceutical compositions containing them
US20030091629A1 (en) * 1998-03-27 2003-05-15 Cima Labs Inc. Sublingual buccal effervescent
US6974590B2 (en) * 1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent
US6264984B1 (en) 1999-12-06 2001-07-24 Bristol-Myers Squibb Company Effervescent histamine H2 antagonist composition
JP2001253826A (ja) * 2000-03-09 2001-09-18 Maruzen Pharmaceut Co Ltd 内服用剤
JP4346311B2 (ja) * 2001-04-27 2009-10-21 京都薬品工業株式会社 発泡性坐剤の保存方法
US20030104017A1 (en) * 2001-10-26 2003-06-05 Boehringer Ingelheim International Gmbh Epinastine formulation for oral administration
MXPA05004648A (es) * 2002-10-30 2005-06-08 Pharmacia Corp Comprimidos orales de liberacion extendida y procedimientos de preparacion y uso de los mismos.
US20050089502A1 (en) * 2003-08-21 2005-04-28 Todd Schansberg Effervescent delivery system
WO2005065317A2 (en) * 2003-12-31 2005-07-21 Cima Labs Inc. Effervescent oral fentanyl dosage form
MXPA06007453A (es) * 2003-12-31 2007-01-31 Cima Labs Inc Forma de dosificacion de opiaceo oral efervescente.
DE602004031462D1 (de) * 2003-12-31 2011-03-31 Cima Labs Inc Allgemein lineare brauseform von fentanyl zur oralen anwendung und verfahren zur verabreichung
WO2005115345A1 (en) * 2004-05-28 2005-12-08 Imaginot Pty Ltd Oral therapeutic compound delivery system
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
US20060100271A1 (en) * 2004-11-08 2006-05-11 Keith Whitehead Stabilized aqueous ranitidine compositions
CA2629904C (en) * 2005-11-28 2018-07-10 Imaginot Pty Ltd. Oral therapeutic compound delivery system
WO2009008895A1 (en) * 2007-07-09 2009-01-15 Cypress Pharmaceutical, Inc. Pleasant-tasting ranitidine formulation
KR20170003414A (ko) * 2015-06-30 2017-01-09 (주)아모레퍼시픽 속붕해형 과립환 모발 세정용 조성물
CN105997922A (zh) * 2016-06-12 2016-10-12 佛山市腾瑞医药科技有限公司 一种盐酸雷尼替丁泡腾片及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1962791A1 (de) * 1969-12-15 1971-06-24 Boehringer Mannheim Gmbh Brausetabletten,Brausepulver und Verfahren zur Herstellung derselben
GB8313217D0 (en) * 1983-05-13 1983-06-22 Glaxo Group Ltd Pharmaceutical compositions
NZ215069A (en) * 1985-03-01 1988-06-30 Reckitt & Colmann Prod Ltd Pharmaceutical composition with histamine h 2 -receptor antagonist
FR2593065B1 (fr) * 1986-01-22 1988-09-09 Smith Kline French Lab Couples effervescents, compositions effervescentes d'antagonistes h2 de l'histamine les contenant et leur preparation.
GB8909793D0 (en) * 1989-04-28 1989-06-14 Beecham Group Plc Pharmaceutical formulation

Also Published As

Publication number Publication date
FR2633181A1 (fr) 1989-12-29
CZ403891A3 (en) 1993-08-11
JPH0245421A (ja) 1990-02-15
US5102665A (en) 1992-04-07
KR940002662B1 (ko) 1994-03-28
ATA154489A (de) 1993-01-15
AT396426B (de) 1993-09-27
NZ229698A (en) 1991-05-28
AU3674489A (en) 1990-01-04
FR2633181B1 (fr) 1992-01-10
AU627194B2 (en) 1992-08-20
LU87541A1 (fr) 1990-02-28
CA1329130C (en) 1994-05-03
SK278823B6 (sk) 1998-03-04
IE892047L (en) 1989-12-24
GB2219940A (en) 1989-12-28
DK314089A (da) 1989-12-25
HU210067A9 (en) 1995-02-28
GB2219940B (en) 1992-01-02
SE8902288L (sv) 1989-12-25
PT90962B (pt) 1994-12-30
IT1232149B (it) 1992-01-25
IT8948116A0 (it) 1989-06-22
IL90731A (en) 1994-04-12
IL90731A0 (en) 1990-01-18
JPH0786086B2 (ja) 1995-09-20
KR910000100A (ko) 1991-01-29
SA90100095B1 (ar) 1999-06-30
ZA894787B (en) 1990-03-28
DK170223B1 (da) 1995-07-03
SE8902288D0 (sv) 1989-06-22
DK314089D0 (da) 1989-06-23
GB8914428D0 (en) 1989-08-09
CZ280886B6 (cs) 1996-04-17
ZW7889A1 (en) 1990-02-21
PH26018A (en) 1992-01-29
BE1005691A4 (fr) 1993-12-21
CY1637A (en) 1992-11-06
NL8901596A (nl) 1990-01-16
SG21892G (en) 1992-04-16
PT90962A (pt) 1989-12-29
DE3920626A1 (de) 1989-12-28
SK403891A3 (en) 1998-03-04
DE3920626C2 (de) 1994-12-22
MY106412A (en) 1995-05-30
ES2015717A6 (es) 1990-09-01
HK33192A (en) 1992-05-15
IE60725B1 (en) 1994-08-10
CH679276A5 (it) 1992-01-31

Similar Documents

Publication Publication Date Title
SE502285C2 (sv) Brusande farmaceutisk komposition innehållande ranitidin, samt förfarande för dess framställning
FI85648B (fi) Foerfarande foer framstaellning av en bornerande, snabbt loeslig komposition som innehaoller ett terapeutiskt medel.
EP1778183B1 (en) Liquid paroxetine compositions
IE892749L (en) Morphine-containing composition
JPH08175976A (ja) 発泡性カップル含有のヒスタミンｈ２−拮抗剤発泡性組成物
JPH08502272A (ja) ラニチジン組成物
ES2223135T3 (es) Composiciones farmaceuticas que contienen vitamina d y calcio, su preparacion y su uso terapeutico.
EA000047B1 (ru) Оральная композиция, содержащая s(+)- этодолак, и способ ее получения
CA2434927C (en) Pharmaceutical compositions with antibiotic activity
JPH0995447A (ja) ビタミン含有組成物
KR101683293B1 (ko) 경구용 조성물
EP0346866A2 (en) Composition for the prophylaxis of osteoporosis
JP4564749B2 (ja) 新規乾燥及び水性エピナスチン−シロップ製剤
JP3389205B2 (ja) 口腔内速崩壊錠
US20190083366A1 (en) Mouthwash granules for an aqueous solution
EP0667149A1 (en) Ibuprofen based effervescent composition
KR101499257B1 (ko) 이소소르비드 제제
US2994639A (en) Antibiotic composition
JP2003192574A (ja) 弱アルカリで安定化される薬剤を含む医薬用液剤
HU226856B1 (en) Pharmaceutical compositions and food additives in solid form containing humic and fulvonic acids
TH51212A (th) ระบบแต่งรสชาติสำหรับองค์ประกอบทางเภสัชกรรมและวิธีการเตรียมองค์ประกอบดังกล่าว

Legal Events

Date Code Title Description
NUG Patent has lapsed